Vanda Pharmaceuticals Inc. (VNDA) Financial Statements (2024 and earlier)

Company Profile

Business Address 2200 PENNSYLVANIA AVE NW
WASHINGTON, DC 20037
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments135,029432,813367,740312,129257,360143,413
Cash and cash equivalents135,02952,07161,03145,07261,00533,627
Short-term investments  380,742306,709267,057196,355109,786
Receivables33,51232,46730,03626,36728,78017,601
Inventory, net of allowances, customer advances and progress billings1,1941,0251,2801,140994840
Inventory1,1941,0251,2801,140994840
Debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss333,368 
Other current assets      2,712
Other undisclosed current assets16,18911,99610,08914,50011,9985,291
Total current assets:519,292478,301409,145354,136299,132169,857
Noncurrent Assets
Inventory, Noncurrent10,2967,2275,0912,8242,8923,316
Operating lease, right-of-use asset8,4009,27210,459 
Property, plant and equipment2,5733,1134,1363,8644,4175,306
Intangible assets, net (including goodwill)18,56520,08121,55923,03724,54226,069
Intangible assets, net (excluding goodwill)18,56520,08121,55923,03724,54226,069
Deferred income tax assets74,03974,87881,516 
Other undisclosed noncurrent assets1,0829201,55099,8871,147877
Total noncurrent assets:114,955115,491124,311129,61232,99835,568
TOTAL ASSETS:634,247593,792533,456483,748332,130205,425
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:45,55134,43831,50927,59021,58420,335
Employee-related liabilities6,8396,51510,9516,5976,3635,323
Accrued liabilities14,22014,60511,91812,9539,62810,349
Other undisclosed accounts payable and accrued liabilities24,49213,3188,6408,0405,5934,663
Other undisclosed current liabilities45,88539,98134,42731,91531,43150,028
Total current liabilities:91,43674,41965,93659,50553,01570,363
Noncurrent Liabilities
Long-term debt and lease obligation:  10,05511,497   
Liabilities, other than long-term debt15,6134,3902,7578433,6933,675
Other liabilities6,8004,3902,7578433,6933,675
Operating lease, liability8,81310,05511,497 
Other undisclosed noncurrent liabilities    12,455  
Total noncurrent liabilities:15,61314,44514,25413,2983,6933,675
Total liabilities:107,04988,86480,19072,80356,70874,038
Equity
Equity, attributable to parent527,198504,928453,266410,945275,422131,387
Common stock575655545245
Additional paid in capital686,235669,223650,300631,307611,587492,802
Accumulated other comprehensive income (loss)(1,193)(175)2392491(34)
Accumulated deficit(157,901)(164,176)(197,328)(220,665)(336,218)(361,426)
Total equity:527,198504,928453,266410,945275,422131,387
TOTAL LIABILITIES AND EQUITY:634,247593,792533,456483,748332,130205,425

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues254,382268,682248,168227,188193,118165,083
Revenue, net165,083
Cost of revenue(24,282)(25,629)(23,364)(24,488)(20,508)(17,848)
Cost of goods and services sold(24,282)(25,629)(23,364)   
Gross profit:230,100243,053224,804202,700172,610147,235
Operating expenses(223,771)(200,888)(197,565)(179,890)(150,872)(164,138)
Operating income (loss):6,32942,16527,23922,81021,738(16,903)
Other undisclosed income from continuing operations before equity method investments, income taxes   4,4166,2183,6081,472
Income (loss) from continuing operations before equity method investments, income taxes:6,32942,16531,65529,02825,346(15,431)
Other undisclosed income from continuing operations before income taxes4,971199    
Income (loss) from continuing operations before income taxes:11,30042,36431,65529,02825,346(15,431)
Income tax expense (benefit)(5,025)(9,212)(8,318)86,525(138)(136)
Income (loss) from continuing operations:6,27533,15223,337115,55325,208(15,567)
Income (loss) before gain (loss) on sale of properties:33,15223,337115,55325,208(15,567)
Net income (loss) available to common stockholders, diluted:6,27533,15223,337115,55325,208(15,567)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net income (loss):6,27533,15223,337115,55325,208(15,567)
Other comprehensive income (loss)(1,018)(414)(10)24835(92)
Comprehensive income (loss), net of tax, attributable to parent:5,25732,73823,327115,80125,243(15,659)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: